Case report of nasal pseudotumor – a rare presentation in severe haemophilia A with high titre inhibitors

1 Mannucci PM, Tuddenham EG. The hemophilias--from royal genes to gene therapy. N Engl J Med 2001; 344(23): 1773–9. doi: 10.1056/NEJM200106073442307. Erratum in: N Engl J Med 2001; 345(5): 384. PMID: 11396445. MannucciPM TuddenhamEG The hemophilias--from royal genes to gene therapy N Engl J Med 2001 344 23 1773 9 10.1056/NEJM200106073442307 Erratum in: N Engl J Med 2001; 345(5): 384. PMID: 11396445. Open DOISearch in Google Scholar

2 Powell JS. Recombinant factor VIII in the management of hemophilia A: current use and future promise. Ther Clin Risk Manag 2009; 5(2): 391–402. doi:10.2147/tcrm.s4412 PowellJS Recombinant factor VIII in the management of hemophilia A: current use and future promise Ther Clin Risk Manag 2009 5 2 391 402 10.2147/tcrm.s4412 Open DOISearch in Google Scholar

3 Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia 2020: 26(Suppl 6): 1–158. doi: 10.1111/hae.14046. SrivastavaA SantagostinoE DougallA WFH Guidelines for the Management of Hemophilia, 3rd edition Haemophilia 2020 26 Suppl 6 1 158 10.1111/hae.14046 Open DOISearch in Google Scholar

4 Ferreira AA, Leite IC, Bustamante-Teixeira MT, et al. Health-related quality of life in hemophilia: results of the Hemophilia-Specific Quality of Life Index (Haem-a-Qol) at a Brazilian blood center. Rev Bras Hematol Hemoter 2013; 35(5): 314–8. doi: 10.5581/1516-8484.20130108. PMID: 24255613; PMCID: PMC3832310. FerreiraAA LeiteIC Bustamante-TeixeiraMT Health-related quality of life in hemophilia: results of the Hemophilia-Specific Quality of Life Index (Haem-a-Qol) at a Brazilian blood center Rev Bras Hematol Hemoter 2013 35 5 314 8 10.5581/1516-8484.20130108 PMID: 24255613; PMCID: PMC3832310. Open DOISearch in Google Scholar

5 Purkait R, Mukherjee A, Naskar S, Bhadra R. Nasal hemophilic pseudotumor: favorable response to radiotherapy. Indian Pediatr 2013; 50(3): 334–5. doi: 10.1007/s13312-013-0071-7. PMID: 23680608. PurkaitR MukherjeeA NaskarS BhadraR Nasal hemophilic pseudotumor: favorable response to radiotherapy Indian Pediatr 2013 50 3 334 5 10.1007/s13312-013-0071-7 PMID: 23680608. Open DOISearch in Google Scholar

6 Gulshan S, Mandal PK, Phukan A, et al. Is low dose a new dose to initiate hemophilia A prophylaxis? – A systematic study in Eastern India. Indian J Pediatr 2020; 87: 345–52. doi: 10.1007/s12098-019-03179-w GulshanS MandalPK PhukanA Is low dose a new dose to initiate hemophilia A prophylaxis? – A systematic study in Eastern India Indian J Pediatr 2020 87 345 52 10.1007/s12098-019-03179-w Open DOISearch in Google Scholar

7 Rodriguez-Merchan EC. Hemophilic pseudotumors: diagnosis and management. Arch Bone JtSurg 2020; 8(2): 121–30. doi:10.22038/abjs.2019.40547.2090. Rodriguez-MerchanEC Hemophilic pseudotumors: diagnosis and management Arch Bone JtSurg 2020 8 2 121 30 10.22038/abjs.2019.40547.2090 Open DOISearch in Google Scholar

8 Ogata Y, Monji M, Kai K, Matsuo M. Nasal hemophilic pseudotumor in a patient with mild hemophilia A and allergic rhinitis. Pediatr Int 2017; 59(2): 237–39. doi: 10.1111/ped.13197. PMID: 28211222. OgataY MonjiM KaiK MatsuoM Nasal hemophilic pseudotumor in a patient with mild hemophilia A and allergic rhinitis Pediatr Int 2017 59 2 237 39 10.1111/ped.13197 PMID: 28211222. Open DOISearch in Google Scholar

9 Valentino LA. Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors. Haemophilia 2020; 16(2): 263–71. doi: 10.1111/j.1365-2516.2009.02126.x. ValentinoLA Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors Haemophilia 2020 16 2 263 71 10.1111/j.1365-2516.2009.02126.x Open DOISearch in Google Scholar

10 Jiang L, Liu Y, Zhang L, Santoro C, Rodriguez A. Rituximab for treating inhibitors in people with inherited severe hemophilia. Cochrane Database Syst Rev 2017; 7(7): CD010810. doi: 10.1002/14651858.CD010810.pub3. Update in: Jiang L, et al. Cochrane Database Syst Rev 2020; 8: CD010810. doi: 10.1002/14651858.CD010810.pub4. JiangL LiuY ZhangL SantoroC RodriguezA Rituximab for treating inhibitors in people with inherited severe hemophilia Cochrane Database Syst Rev 2017 7 7 CD010810 10.1002/14651858.CD010810.pub3 Update in: Jiang L, et al. Cochrane Database Syst Rev 2020; 8: CD010810. doi: 10.1002/14651858.CD010810.pub4. Open DOISearch in Google Scholar